TOP NEWS: AstraZeneca's Tezspire and Koselugo approved in Japan
(Alliance News) - AstraZeneca PLC on Tuesday said its Tezspire and Koselugo drugs have been approved in Japan for the treatment of severe asthma and patients that suffer from a rare genetic condition, respectively.
Read more